We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+28.53%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.3B
AUM Growth
+$4.26B
Cap. Flow
+$1.91B
Cap. Flow %
13.37%
Top 10 Hldgs %
16.38%
Holding
2,145
New
560
Increased
472
Reduced
391
Closed
662

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$139M
2
PG icon
Procter & Gamble
PG
+$118M
3
TFX icon
Teleflex
TFX
+$90.1M
4
MSFT icon
Microsoft
MSFT
+$89.4M
5
UBS icon
UBS Group
UBS
+$77.2M

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$203M
2
AGN
Allergan plc
AGN
+$177M
3
MLNX
Mellanox Technologies, Ltd.
MLNX
+$118M
4
AMZN icon
Amazon
AMZN
+$115M
5
LIN icon
Linde
LIN
+$89.1M

Sector Composition

Rank Sector Weight
1 Healthcare 21.29%
2 Consumer Discretionary 15.87%
3 Technology 12.26%
4 Financials 12.01%
5 Industrials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCOM
1351
DELISTED
Points.com Inc. Common Shares
PCOM
$266K ﹤0.01%
29,232
-46,160
-61% -$412K
ING icon
1352
ING
ING
$93.8B
$265K ﹤0.01%
38,378
+12,834
+50% +$77.9K
RPM icon
1353
RPM International
RPM
$13.7B
$265K ﹤0.01%
+3,524
New +$245K
KELYA icon
1354
Kelly Services Class A
KELYA
$526M
$263K ﹤0.01%
16,645
+1,883
+13% +$26.9K
FIRY
1355
Firy Inc
FIRY
$127M
$263K ﹤0.01%
+1,197
New +$246K
MDP
1356
DELISTED
Meredith Corporation
MDP
$263K ﹤0.01%
18,084
-159
-0.9% -$2.31K
SYRS
1357
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$261K ﹤0.01%
+2,446
New +$220K
AB icon
1358
AllianceBernstein
AB
$3.47B
$256K ﹤0.01%
+9,390
New +$218K
HBNC icon
1359
Horizon Bancorp
HBNC
$1.03B
$256K ﹤0.01%
23,903
+20,603
+624% +$210K
ON icon
1360
ON Semiconductor
ON
$33.8B
$255K ﹤0.01%
+12,884
New +$210K
GAIA icon
1361
Gaia
GAIA
$47.3M
$254K ﹤0.01%
30,360
-4,332
-12% -$37.6K
FOX icon
1362
Fox Class B
FOX
$20.7B
$253K ﹤0.01%
+9,413
New +$250K
IYC icon
1363
iShares US Consumer Discretionary ETF
IYC
$1.12B
$253K ﹤0.01%
4,620
-1,064
-19% -$55K
WCC.PRA
1364
DELISTED
WESCO International, Inc. Depositary Shares each representing 1/1,000th interest in a share of Series A Fixed-Rate Reset Cumulative Perpetual Preferred Stock
WCC.PRA
$250K ﹤0.01%
+9,442
New +$250K
CVLG icon
1365
Covenant Logistics
CVLG
$1.18B
$249K ﹤0.01%
+34,558
New +$176K
BOOM icon
1366
DMC Global
BOOM
$121M
$248K ﹤0.01%
8,971
-1,371
-13% -$37.8K
EVA
1367
DELISTED
Enviva Inc.
EVA
$245K ﹤0.01%
+6,773
New +$225K
HFWA icon
1368
Heritage Financial
HFWA
$1.24B
$244K ﹤0.01%
+12,205
New +$230K
TGH
1369
DELISTED
Textainer Group Holdings limited
TGH
$243K ﹤0.01%
29,660
+27,453
+1,244% +$225K
BCRX icon
1370
BioCryst Pharmaceuticals
BCRX
$2.37B
$239K ﹤0.01%
50,277
-21,383
-30% -$85.4K
CTT
1371
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$239K ﹤0.01%
+26,995
New +$209K
SLGN icon
1372
Silgan Holdings
SLGN
$4.91B
$238K ﹤0.01%
7,359
-79,780
-92% -$2.6M
EWBC icon
1373
East-West Bancorp
EWBC
$17.9B
$237K ﹤0.01%
6,543
-17,664
-73% -$590K
TIGR
1374
UP Fintech Holding
TIGR
$845M
$237K ﹤0.01%
+56,927
New +$187K
HCC icon
1375
Warrior Met Coal
HCC
$4.23B
$236K ﹤0.01%
15,317
+11,218
+274% +$153K

Similar funds

Marshall Wace's Q2 2020 Portfolio in Review

As of Q2 2020, Marshall Wace held 2,145 positions worth $14.3B, up 43% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $1.91B of net new capital in Q2 2020, opening 560 new positions and adding to 472 existing holdings. Its largest new stake was JPMorgan Chase: 783,355 shares worth $73.7M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was PayPal, an estimated $203M trimmed.

  • Marshall Wace's largest Q2 2020 buy was JPMorgan Chase: 783,355 shares worth $73.7M.
  • Marshall Wace added most to T-Mobile US in Q2 2020, an estimated $139M increase.
  • Marshall Wace's biggest Q2 2020 reduction was PayPal, cutting an estimated $203M.
  • Marshall Wace fully exited Allergan plc in Q2 2020, selling an estimated $177M.
  • Marshall Wace's ten largest holdings make up 16% of its $14.3B portfolio in Q2 2020.
  • Marshall Wace opened 560 new positions and closed 662 in Q2 2020.
  • Marshall Wace's portfolio value rose 43% quarter-over-quarter to $14.3B.

Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.